Clinical Laboratory and Nutritional Sciences
Lecturer Brenda Geiger (Graduate Coordinator, Pharmaceutical Sciences)
Brenda Geiger earned an MBA in Business Administration and an MEng in Pharmaceutical Engineering from the University of Michigan, and a PhD in Pharmacology and Experimental Therapeutics from Tufts University. Dr. Geiger's expertise is in physiological chemistry and pharmacology. She has extensive experience working in the pharmaceutical industry. Her research focuses on obesity and the effects of melanin-concentrating hormone.
Professor Garry Handelman (Interim Chair, Pharmaceutical Sciences)
Garry Handelman earned his Ph.D. in Biochemistry from Tufts University. His research program focuses on the nature of pathological changes that occur in long-term renal failure, with a goal of better understanding how to care for patients on dialysis. He and his team have studied oxidant stress (breath ethane, isoprostanes, and inflammatory markers) and the influence of dietary antioxidant supplementation (vitamin E and selenium). They are studying vitamin C levels in patients on dialysis, seeking to determine if patients would benefit from interventions to raise their plasma vitamin C levels. They are also studying the biology of anemia in these patients, and are seeking better ways of administering iron to avoid chronic anemia in dialysis. Another research area is investigating strategies to raise the level of carotenoids in the retina, involving egg consumption and other interventions. In addition, Prof. Handelman has worked with other faculty at Lowell and elsewhere to better understand the prevention of diabetes and hypertension through diet and exercise. This is a major developing focus of his research, since these diseases are highly preventable through life style modifications. Current research questions include better diets that do not elevate blood glucose levels (low-glycemic diets), since these diets may lead to less obesity.